Global Medical Advisor
Since January 2014
Responsible for global medical affairs functions in the pre-launch and launch phase of a first-in-class, specialty product in Idiopathic Pulmonary Fibrosis (IPF) - including scientific platform development, external experts management, global medical education initiatives and phase IV clinical program.
Assistant Professor & Academic collaborator
Since September 2010
Assistant professor at the Strategy and General Management Department (2010-13). Lecturer at the MBA programs and tutor for the end-of-program project at the BBA grade. Currently serving as academic collaborator for that same department.
Director, Marketing and Business Development
March 2011 --- June 2013
Responsible for managing the MKT Department (3 direct reports) focused both on marketed hospital specialty drugs and on new products market readiness. Also, responsible for building up the local Market Access function including the development of a MA strategy and the launch of a field-based MA KAM team (3 direct reports, ad interim management).
Global Associate Brand Director
March 2009 --- February 2011
Responsible for managing a cross-functional global brand team to develop the commercialization strategy of two products in phase III clinical development for orphan indications in cardiovascular and respiratory therapeutic areas (Pulmonary Arterial Hypertension - PAH, Systemic Sclerosis - SSc, Idiopathic Pulmonary Fibrosis - IPF) including phase IV clinical program and LOC launch readiness initiatives.
January 2007 --- February 2009
Responsible for Brand Plan and Budget development and execution of a hospital specialty drug with several orphan indications in cardio-pulmonary and autoinmune disease.
January 2005 --- December 2006
Responsible for medical affairs of a hospital specialty drug with several orphan indications in cardio-pulmonary and autoinmune disease, including phase IV clinical program and IIS management, SF scientific training and commercial activities compliance.
Resident in Psychiatry
May 2000 --- December 2004
Board-certified psychiatrist with specific focus on bipolar disorders and addictions.Internship at the regional HTA Agency (AiAQS) with specific training in clinical research methodology and health economics.
High Performance Leadership in Business Administration and Management, General from IMD (International Institute for Management Development) - Business Programs in 2012
Team Leadership Diplomma in from American Management Association in 2011
Masters; MBA in Business Administration from ESADE Business School in 2008
MIR, Psychiatry in Psychiatry Residency Program from Universitat de Barcelona in 2004
Doctor of Medicine (MD) in Licenciado en Medicina y Cirugía, MD from Universitat de Barcelona in 1999